FGEN - Fibrogen Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - FGEN (921299)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
90 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
S90-0+1-1-9

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

DM
2017-03-20
FGENNeff Thomas BCEOS - Sale+OE$24.34-38,6363,550,549-1%-$940,3050
2017-03-14
FGENYu K PeonyChief Medical OfficerS - Sale$25.41-7,851231,046-3%-$199,45800
DM
2017-03-14
FGENNeff Thomas BCEOS - Sale+OE$25.07-38,636368,160-9%-$968,47100
2017-03-10
FGENCotroneo PatVP, Finance, CFOS - Sale$25.30-7,851157,905-5%-$198,630+10
DM
2017-03-01
FGENCotroneo PatVP, Finance, CFOS - Sale+OE$26.00-6,500132,248-5%-$169,000-4+2
2017-02-16
FGENKurkijarvi KaleviDirS - Sale$24.45-2,00040,000-5%-$48,900-1-4+2
DM
2017-02-13
FGENNeff Thomas BCEOS - Sale+OE$23.94-38,6363,480,341-1%-$924,7650-2+3
DM
2017-02-08
FGENNeff Thomas BCEOS - Sale+OE$23.46-37,7983,481,177-1%-$886,7410+2+9
DM
2017-01-26
FGENNeff Thomas BCEO, 10%S - Sale+OE$23.29-37,7983,490,793-1%-$880,315-60+7
2017-01-19
FGENKurkijarvi KaleviDirS - Sale$24.90-2,00042,000-5%-$49,800-6-10-4
D
2017-01-11
FGENCotroneo PatVP, Finance, CFOS - Sale+OE$24.00-6,500132,248-5%-$156,000-70-6
DM
2017-01-11
FGENNeff Thomas BCEO, 10%S - Sale+OE$23.85-37,7983,500,409-1%-$901,522-70-6
2017-01-10
FGENYu K PeonyChief Medical OfficerS - Sale$23.56-5,000202,448-2%-$117,800+30-3
DM
2016-12-27
FGENNeff Thomas BCEO, 10%S - Sale+OE$20.74-37,7983,510,025-1%-$783,931-2+50
2016-12-16
FGENRiggs Rory BDirS - Sale$20.87-20,0001,065,913-2%-$417,310-2-4+21
2016-12-14
FGENYu K PeonyChief Medical OfficerS - Sale$20.65-2,344207,448-1%-$48,404-2-4+21
2016-12-12
FGENCotroneo PatVP, Finance, CFOS - Sale$22.05-2,344132,248-2%-$51,685+4-1+25
DM
2016-12-12
FGENNeff Thomas BCEO, 10%S - Sale+OE$21.24-37,7983,519,643-1%-$802,828+4-1+25
DM
2016-11-28
FGENNeff Thomas BCEO, 10%S - Sale+OE$22.80-37,7983,533,948-1%-$861,794-7+2-2
DM
2016-11-17
FGENKearns Thomas F JrDirS - Sale+OE$22.40-18,000270,564-6%-$403,1600+1-14
DM
2016-11-16
FGENNeff Thomas BCEO, 10%S - Sale+OE$22.29-37,7983,543,564-1%-$842,5170+1-14
DM
2016-10-31
FGENNeff Thomas BCEO, 10%S - Sale+OE$16.75-37,7983,553,180-1%-$633,305-2-4+33
DM
2016-10-18
FGENNeff Thomas BCEO, 10%S - Sale+OE$17.75-37,7983,562,796-1%-$670,915+2-3+25
DM
2016-10-03
FGENNeff Thomas BCEO, 10%S - Sale+OE$20.61-37,7983,572,412-1%-$779,017-3-6-21
DM
2016-09-20
FGENNeff Thomas BCEO, 10%S - Sale+OE$21.66-37,7983,582,028-1%-$818,70500-21+13
2016-09-14
FGENYu K PeonyChief Medical OfficerS - Sale$18.66-2,345206,502-1%-$43,7580+10-10+27
2016-09-12
FGENCotroneo PatVP, Finance, CFOS - Sale$18.22-2,345134,359-2%-$42,726+5+13-5+34
DM
2016-09-08
FGENNeff Thomas BCEO, 10%S - Sale+OE$18.98-37,7983,591,644-1%-$717,595+4+9+9+39
DM
2016-08-25
FGENNeff Thomas BCEO, 10%S - Sale+OE$17.80-37,7983,605,948-1%-$672,7050+1+27+41
DM
2016-07-26
FGENNeff Thomas BCEO, 10%S - Sale+OE$18.38-37,7983,615,564-1%-$694,548+1+6-7+23
M
2016-07-12
FGENNeff Thomas BCEO, 10%S - Sale$17.50-27,0003,625,180-1%-$472,419+3+6+11
M
2016-06-28
FGENNeff Thomas BCEO, 10%S - Sale$16.02-27,0003,652,180-1%-$432,574+2+4+17
M
2016-06-14
FGENNeff Thomas BCEO, 10%S - Sale$16.48-27,0003,679,180-1%-$444,960-4-5+5+26
2016-06-15
FGENCotroneo PatVP, Finance, CFOS - Sale$16.49-1,796138,114-1%-$29,616-4-5+5+26
2016-06-10
FGENYu K PeonyChief Medical OfficerS - Sale$17.96-2,344210,257-1%-$42,098-1-4+2+34
M
2016-06-02
FGENNeff Thomas BCEO, 10%S - Sale$18.98-27,0003,706,180-1%-$512,595+6-2-10+18
M
2016-05-19
FGENNeff Thomas BCEO, 10%S - Sale$17.68-27,0003,737,869-1%-$477,4240+2-12+22
2016-05-16
FGENYu K PeonyChief Medical OfficerS - Sale$17.60-6,107214,011-3%-$107,483-3+1-9+22
2016-05-16
FGENCotroneo PatVP, Finance, CFOS - Sale$17.60-6,107141,868-4%-$107,483-3+1-9+22
M
2016-05-02
FGENNeff Thomas BCEO, 10%S - Sale$17.78-27,0003,764,869-1%-$480,060-3-2+10-2
M
2016-04-19
FGENNeff Thomas BCEO, 10%S - Sale$19.98-27,0003,791,869-1%-$539,460+4+1-8-9
M
2016-04-04
FGENNeff Thomas BCEO, 10%S - Sale$21.11-27,0003,818,869-1%-$570,043+7-2-170
D
2016-04-01
FGENValone Frank H MdChief Medical OfficerS - Sale+OE$21.11-10,750108,684-9%-$226,941-1+1-12-3
M
2016-03-21
FGENNeff Thomas BCEO, 10%S - Sale$18.74-27,0003,845,869-1%-$505,872-2+4+3+12
M
2016-03-07
FGENNeff Thomas BCEO, 10%S - Sale$19.62-27,0003,872,869-1%-$529,6130+5+18-3
D
2016-03-01
FGENValone Frank H MdChief Medical OfficerS - Sale+OE$16.84-10,750112,605-9%-$181,040+4-1+14-6
DM
2016-02-22
FGENNeff Thomas BCEO, 10%S - Sale+OE$19.11-27,0003,908,423-1%-$515,850-1-3+2+3
D
2016-02-16
FGENValone Frank H MdChief Medical OfficerS - Sale+OE$18.41-10,750100,840-10%-$197,943+3-4-14-5
M
2016-02-09
FGENNeff Thomas BCEO, 10%S - Sale$15.31-27,0003,835,423-1%-$413,360+3+14+10+7
M
2016-01-28
FGENNeff Thomas BCEO, 10%S - Sale$19.41-27,0003,862,423-1%-$524,015-4-14-15-7
2016-01-21
FGENKearns Thomas F JrDirS - Sale$22.08-1,572270,564-1%-$34,710+1-10-7-15
M
2016-01-13
FGENNeff Thomas BCEO, 10%S - Sale$23.69-27,0003,889,423-1%-$639,683-5-7-16-22
M
2015-12-23
FGENKearns Thomas F JrDirS - Sale$30.88-7,800272,136-3%-$240,825+4+1-35-49
M
2015-12-22
FGENNeff Thomas BCEO, 10%S - Sale$30.10-27,0003,916,423-1%-$812,703-10-34-51
2015-12-15
FGENCotroneo PatVP, Finance, CFOS - Sale$28.95-837107,325-1%-$24,231-5+2-30-49
2015-12-10
FGENYu K PeonyVP, Clinical DevelopmentS - Sale$28.96-1,093176,595-1%-$31,653+1+6-13-39
M
2015-12-10
FGENNeff Thomas BCEO, 10%S - Sale$29.59-27,0003,943,423-1%-$798,815+1+6-13-39
D
2015-12-08
FGENMadero MiguelDirS - Sale+OE$30.49-40,386425,246-9%-$1,231,369-60-19-45
M
2015-11-25
FGENYu K PeonyVP, Clinical DevelopmentS - Sale$30.00-5,000178,345-3%-$150,0000+2+5-37
D
2015-11-25
FGENCotroneo PatVP, Finance, CFOS - Sale+OE$30.00-5,000107,775-4%-$150,0000+2+5-37
M
2015-11-23
FGENNeff Thomas BCEO, 10%S - Sale$28.49-27,0003,972,705-1%-$769,125+1+2+5-37
M
2015-11-23
FGENKearns Thomas F JrDirS - Sale$28.51-7,800279,936-3%-$222,389+1+2+5-37
2015-11-17
FGENYu K PeonyVP, Clinical DevelopmentS - Sale$28.00-5,000183,345-3%-$140,000-3+8+11-36
M
2015-11-09
FGENYu K PeonyVP, Clinical DevelopmentS - Sale$25.61-5,000187,904-3%-$128,075-6-3+7-36
D
2015-11-02
FGENValone Frank H MdChief Medical OfficerS - Sale+OE$23.18-10,00084,044-11%-$231,793-5+1+12-39
M
2015-10-29
FGENNeff Thomas BCEO, 10%S - Sale$24.06-27,0003,999,705-1%-$649,554+7+9+27-21
M
2015-10-20
FGENKearns Thomas F JrDirS - Sale$23.83-7,800287,736-3%-$185,903+3+13+22-4
D
2015-10-19
FGENValone Frank H MdChief Medical OfficerS - Sale+OE$23.00-10,00084,044-11%-$230,000-7-1+17-13
2015-10-19
FGENYu K PeonyVP, Clinical DevelopmentS - Sale$24.00-5,000192,904-3%-$120,000-7-1+17-13
M
2015-10-15
FGENNeff Thomas BCEO, 10%S - Sale$21.86-27,0004,026,705-1%-$590,149+16-1+19-5
M
2015-10-15
FGENYu K PeonyVP, Clinical DevelopmentS - Sale$21.46-5,000197,904-2%-$107,300+16-1+19-5
M
2015-10-01
FGENNeff Thomas BCEO, 10%S - Sale$21.59-27,0004,053,705-1%-$583,0560-5+3-7
D
2015-10-01
FGENValone Frank H MdChief Medical OfficerS - Sale+OE$21.38-10,00084,044-11%-$213,7820-5+3-7
DM
2015-09-17
FGENNeff Thomas BCEO, 10%S - Sale+OE$29.10-27,0004,080,705-1%-$785,691-6-11-27-41
M
2015-09-11
FGENRiggs Rory BDirS - Sale$27.61-50,0001,085,913-4%-$1,380,664-1-1-28-39
2015-09-11
FGENMadero MiguelDirS - Sale$27.66-20,600381,632-5%-$569,796-1-1-28-39
D
2015-09-15
FGENCotroneo PatVP, Finance, CFOS - Sale+OE$27.95-1,093107,498-1%-$30,549-1-1-28-39
2015-09-10
FGENYu K PeonyVP, Clinical DevelopmentS - Sale$27.84-1,093202,904-1%-$30,430+1+6-24-31
DM
2015-09-08
FGENCotroneo PatVP, Finance, CFOS - Sale+OE$27.33-7,500107,251-7%-$205,000-10-25-39
D
2015-09-04
FGENNeff Thomas BCEO, 10%S - Sale+OE$22.88-13,5004,088,7670%-$308,884+13+20-3-13
D
2015-09-01
FGENValone Frank H MdChief Medical OfficerS - Sale+OE$23.58-10,00084,044-11%-$235,782+2+23-1-13
D
2015-09-03
FGENNeff Thomas BCEO, 10%S - Sale+OE$22.92-13,5004,092,7980%-$309,360+2+23-1-13
DM
2015-08-05
FGENNeff Thomas BCEO, 10%S - Sale+OE$23.32-27,0004,099,111-1%-$629,636+20+4-25
D
2015-08-03
FGENValone Frank H MdChief Medical OfficerS - Sale+OE$23.37-10,00084,748-11%-$233,731-1-8-1-23
DM
2015-07-22
FGENNeff Thomas BCEO, 10%S - Sale+OE$24.71-27,0004,107,173-1%-$667,1700-5-5-13
D
2015-07-20
FGENValone Frank H MdChief Medical OfficerS - Sale+OE$23.70-1,00084,748-1%-$23,702-1-30-13
DM
2015-07-17
FGENCotroneo PatVP, Finance, CFOS - Sale+OE$23.47-7,881105,818-7%-$185,001-1-30-13
DM
2015-07-08
FGENNeff Thomas BCEO, 10%S - Sale+OE$22.11-27,0004,115,235-1%-$596,8350+4-3+19
2015-07-06
FGENYu K PeonyVP, Clinical DevelopmentS - Sale$22.69-5,381204,654-3%-$122,097-4-1+4+33
DM
2015-06-24
FGENNeff Thomas BCEO, 10%S - Sale+OE$23.57-27,0004,123,297-1%-$636,324-6-6-2+29

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top